Last update:

Oncology & Cancer news

Oncology & Cancer

Scientists show targeting cancer stem cells can prevent gastric cancer recurrence

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified the specific cells responsible for gastric cancer's tendency to return after treatment. The study also demonstrated that eliminating ...

Oncology & Cancer

Cancer's hidden 'safety switch': Silencing TAK1 gene could boost immunotherapy performance

Australian researchers have discovered that the TAK1 gene helps cancer cells survive attack from the immune system, revealing a mechanism that may limit the effectiveness of immunotherapy treatments.

Oncology & Cancer

New Raman imaging system detects subtle tumor signals

Researchers have developed a new compact Raman imaging system that is sensitive enough to differentiate between tumor and normal tissue. The system offers a promising route to earlier cancer detection and to making molecular ...

Oncology & Cancer

AI can help detect kidney cancer faster

Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated in a study published in Communications Medicine.

Oncology & Cancer

Subtyping colorectal cancer may improve patient outcome predictions

Colorectal cancer, or CRC, is the world's second most lethal cancer based on the number of deaths, and is the third most prevalent malignant tumor. Doctors and patients have long been hoping for better diagnostics for prognosis, ...

Oncology & Cancer

WISDOM trial weighs risk-based cancer screening

University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based breast cancer screening and annual mammography. Rates of stage ≥IIB breast cancers met a noninferiority threshold under ...

Oncology & Cancer

Engineered dendritic cells boost cancer immunotherapy

EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work, covered in two papers, turns the previously lab-based method into a full-blown immunotherapy strategy.

Oncology & Cancer

RNA-based molecule enhances therapies against pancreatic cancer

A research group at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has identified a candidate molecule that could improve current therapies against pancreatic cancer. The team designed the new molecule, ...

Oncology & Cancer

New risk score helps predict pancreatic cancer recurrence

Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients with pancreatic neuroendocrine tumors (PanNETs) need closer monitoring because their cancer is ...

Oncology & Cancer

How to reduce risk of lymphedema after head and neck cancer

Lymphedema after head and neck cancer is considerably more common than previously assumed and can persist long after cancer treatment has finished. Researchers at Lund University in Sweden have discovered that patients with ...

Oncology & Cancer

New technology reduces false positives in breast ultrasounds

New ultrasound technology developed at Johns Hopkins can distinguish fluid from solid breast masses with near perfect accuracy, an advance that could save patients, especially those with dense breast tissue, from unnecessary ...

Oncology & Cancer

Dietary changes could provide a therapeutic avenue for brain cancer

Glioblastomas are the deadliest form of malignant brain tumor, and most patients diagnosed with the disease live only one or two years. In these tumors, normal cells in the brain become aggressive, growing rapidly and invading ...

Oncology & Cancer

Shampoo-like gel could help chemo patients keep their hair

Cancer fighters know that losing their hair is often part of the battle, but Michigan State University researchers have developed a shampoo-like gel that has been tested in animal models and could protect hair from falling ...

Oncology & Cancer

Investigators create urine-based test to ID prostate cancers

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital and four other institutions have devised a novel method to test for prostate cancer using biomarkers present in urine. This approach ...